BMY vs NVR · P/E 17, rev $24.46B vs P/E 15, rev $4.21B
Bristol-Myers Squibb Company (BMY) versus NVR Inc (NVR) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
NVR Inc (NVR) is a residential construction company listed on NYSE.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported NVR revenue for 2026-06-30 was $4.21B. Net income was $434.8M. NVR currently screens at market cap $16.94B and trailing P/E 15.3.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. NVR currently screens at market cap $16.94B and trailing P/E 15.3.
Not investment advice. Open the BMY and NVR stock pages for the full models.
Not investment advice.